Solara Active Pharma Sciences announced that its new state of the art multipurpose API manufacturing facility at Vishakhapatnam Andhra Pradesh had received Certificate of Suitability CEP approval for the manufacture of Ibuprofen API from European Directorate for the Quality of Medicines EDQM the first international regulatory approval for this new facility With this key approval Solara has CEP approval for two manufacturing facilities for Ibuprofen API the other being its dedicated manufacturing facility located at Puducherry India Solara also expects series of other international regulatory approvals for its Vizag facility including USFDA
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
